Wall Street analysts expect The Advisory Board Company (NASDAQ:ABCO) to post $202.29 million in sales for the current fiscal quarter, according to Zacks. Ten analysts have provided estimates for The Advisory Board’s earnings, with the highest sales estimate coming in at $210.70 million and the lowest estimate coming in at $194.00 million. The Advisory Board posted sales of $200.46 million in the same quarter last year, which suggests a positive year-over-year growth rate of 0.9%. The firm is expected to announce its next earnings report on Tuesday, November 7th.

On average, analysts expect that The Advisory Board will report full year sales of $202.29 million for the current year, with estimates ranging from $792.87 million to $819.50 million. For the next financial year, analysts expect that the company will report sales of $845.76 million per share, with estimates ranging from $821.50 million to $862.00 million. Zacks’ sales averages are an average based on a survey of sell-side research firms that follow The Advisory Board.

The Advisory Board (NASDAQ:ABCO) last released its earnings results on Tuesday, August 8th. The business services provider reported $0.24 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.08). The Advisory Board had a return on equity of 12.69% and a net margin of 13.65%. The company had revenue of $200.30 million during the quarter, compared to analysts’ expectations of $196.16 million. During the same quarter in the previous year, the company earned $0.46 EPS. The firm’s quarterly revenue was up 1.0% compared to the same quarter last year.

A number of analysts have recently commented on ABCO shares. Zacks Investment Research raised shares of The Advisory Board from a “hold” rating to a “buy” rating and set a $58.00 price objective on the stock in a research report on Tuesday, July 4th. Stifel Nicolaus reissued a “hold” rating and issued a $53.00 price objective (up previously from $48.00) on shares of The Advisory Board in a research report on Thursday, July 6th. KeyCorp reissued a “hold” rating on shares of The Advisory Board in a research report on Friday, September 1st. Cantor Fitzgerald reissued a “hold” rating and issued a $54.00 price objective (up previously from $45.00) on shares of The Advisory Board in a research report on Tuesday, August 29th. Finally, Canaccord Genuity lowered shares of The Advisory Board from a “buy” rating to a “hold” rating and cut their price objective for the stock from $56.00 to $54.29 in a research report on Tuesday, August 29th. Two research analysts have rated the stock with a sell rating, twelve have issued a hold rating and three have given a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $51.95.

The Advisory Board (NASDAQ ABCO) opened at 53.85 on Tuesday. The Advisory Board has a 52 week low of $24.85 and a 52 week high of $59.50. The stock’s 50 day moving average is $53.64 and its 200 day moving average is $52.37. The firm has a market cap of $2.19 billion, a price-to-earnings ratio of 20.45 and a beta of 1.33.

COPYRIGHT VIOLATION WARNING: This story was published by American Banking News and is the property of of American Banking News. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright law. The original version of this story can be read at https://www.americanbankingnews.com/2017/10/24/zacks-brokerages-expect-the-advisory-board-company-abco-will-announce-quarterly-sales-of-202-29-million.html.

Large investors have recently added to or reduced their stakes in the business. Victory Capital Management Inc. acquired a new position in shares of The Advisory Board in the first quarter valued at $109,000. Rockefeller Financial Services Inc. acquired a new position in shares of The Advisory Board in the second quarter valued at $137,000. Eqis Capital Management Inc. acquired a new position in shares of The Advisory Board in the second quarter valued at $204,000. First Capital Advisors Group LLC. acquired a new position in shares of The Advisory Board in the second quarter valued at $221,000. Finally, Cubist Systematic Strategies LLC acquired a new position in shares of The Advisory Board in the second quarter valued at $221,000.

The Advisory Board Company Profile

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company offers subscription-based membership programs, software and data-enabled services. All of its programs are rooted in best practices and extends across four areas, including Best practices research, Technology, Data-enabled services and Consulting services.

Get a free copy of the Zacks research report on The Advisory Board (ABCO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for The Advisory Board Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Company and related companies with MarketBeat.com's FREE daily email newsletter.